Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 227

The DOI matches its Crossref record.

Amantadine: The journey from fighting flu to treating Parkinson disease

Hubsher, G., Haider, M., Okun, M.S.·2012·Neurology

Abstract

OBJECTIVE: To explore how amantadine transitioned from an anti-flu drug to antiparkinsonian agent. METHODS: A review of the historical literature on the use of amantadine from 1966 to the present was performed. RESULTS: Amantadine was originally introduced and utilized as an antiviral medication. A single patient noticed relief in her Parkinson disease (PD) symptoms after taking amantadine for a flu infection, and this observation sparked an interest, and several important studies that eventually led to a new drug indication. CONCLUSION: Amantadine has over the years fallen out of favor as a drug to address influenza infection; however, it has become part of the arsenal utilized for early symptomatic treatment of PD, as well an option for treating dyskinesia.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1212/wnl.0b013e31824e8f0d

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 227

Metadata

Authors
Hubsher, G., Haider, M., & Okun, M. S.
Venue
Neurology
Published
2012-04-03
Volume
78
Issue
14
Pages
1096-1099
ISSN
  • 0028-3878 (ISSN-L)
  • 1526-632X
OpenAlex
W2036385867
Cited by
227
References
0
FWCI
5.61
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Amantadine: The journey from fighting flu to treating Parkinson disease. https://app.cochat.ai/papers/10.1212/wnl.0b013e31824e8f0d
The paper
Hubsher, G., Haider, M., & Okun, M. S. (2012). Amantadine: The journey from fighting flu to treating Parkinson disease. Neurology. https://doi.org/10.1212/wnl.0b013e31824e8f0d

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.